Place · Level 3
Reproductive · Pregnancy
孕前 3 个月叶酸 · 神经管 21-28 天关闭 · 铁需求翻倍 · DHA 胎儿脑 · HPG 轴 + 更年期 + 男 T · 拆穿天然激素
Last updated
Story path
- 1Pre-conception · 3-month windowPre-conception · 3-month window
- 2Neural tube · days 21–28Neural tube · days 21–28
- 3Pregnancy iron · doubledPregnancy iron · doubled
- 4DHA · fetal brainDHA · fetal brain
- 5Menopause + male TMenopause + male T
- 6Fertility · the timeline you don't seeFertility · the timeline you don't see
Chapter 1
Pre-conception · 3-month window
Pre-conception · 3-month window
The 3 months before conception is the highest-ROI nutritional window — the payoff far exceeds any mid- or late-pregnancy rescue. But Chinese-language internet discussion of this often gets diluted by marketing of 'pregnancy milk powder + DHA gummies + hyaluronic-acid drinks'.
The real evidence-based checklist (ACOG 2021 / WHO 2016 / China pre-pregnancy guidelines) breaks into three blocks.
Three things to do before the starting gun:
1. Women take 400-800 μg folate daily, starting 3 months before conception and continuing to gestational week 12. Women with a prior NTD history, antiepileptic drug (AED) use, or type 1 / type 2 diabetes may need a high dose, but that is a physician-initiated prescribing decision, not a self-escalation; a raised BMI alone is not a reason to increase the dose (NICE 2025). Folate is the single strongest intervention for reducing neural-tube defects (NTD) — 50-70%.
2. Reach a reasonable BMI (18.5-23.9). BMI > 30 → 2-4× the risk of gestational diabetes, preeclampsia, macrosomia, C-section; BMI < 18.5 → preterm birth, low birth weight, fetal growth restriction. Paternal BMI also affects sperm quality and offspring metabolism (Salas-Huetos 2017).
3. Quit smoking, limit alcohol — both partners. Any level of alcohol during pregnancy can cause fetal alcohol spectrum disorder (FASD); WHO and AAP recommend both partners abstain for 3 months pre-conception. Smoking reduces placental blood flow, raising low birth weight and SIDS risk.
Pre-conception blood screening (ACOG 2021):
CBC — screen for iron-deficiency anemiathyroid-stimulating hormone: A pituitary hormone that prods the thyroid to work — it rises when the thyroid is underactive. — subclinical hypothyroidism affects embryonic neurodevelopment25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. — supplement if < 50 nmol/LVitamin B12 — required for vegans (low B12 + high folate is the 'folate trap')Rubella / varicella IgG — vaccinate before pregnancy if negativeHIV / syphilis / hepatitis BPeriodontitis screen (severe periodontitis is linked to preterm birth, B-tier evidence)
Chronic-disease stabilization matters far more than supplements:
Diabetes: HbA1c < 6.5%Hypertension: women on ACEi / ARB must switch (contraindicated in pregnancy)Hyperthyroidism / hypothyroidism: stabilize before conceptionDepression / anxiety medications: review safety with psychiatry
Getting the 3 months before conception right beats taking 20 supplements during mid-to-late pregnancy. This is one of the rare nutrition windows where early intervention compounds.
The real evidence-based checklist (ACOG 2021 / WHO 2016 / China pre-pregnancy guidelines) breaks into three blocks.
Three things to do before the starting gun:
1. Women take 400-800 μg folate daily, starting 3 months before conception and continuing to gestational week 12. Women with a prior NTD history, antiepileptic drug (AED) use, or type 1 / type 2 diabetes may need a high dose, but that is a physician-initiated prescribing decision, not a self-escalation; a raised BMI alone is not a reason to increase the dose (NICE 2025). Folate is the single strongest intervention for reducing neural-tube defects (NTD) — 50-70%.
2. Reach a reasonable BMI (18.5-23.9). BMI > 30 → 2-4× the risk of gestational diabetes, preeclampsia, macrosomia, C-section; BMI < 18.5 → preterm birth, low birth weight, fetal growth restriction. Paternal BMI also affects sperm quality and offspring metabolism (Salas-Huetos 2017).
3. Quit smoking, limit alcohol — both partners. Any level of alcohol during pregnancy can cause fetal alcohol spectrum disorder (FASD); WHO and AAP recommend both partners abstain for 3 months pre-conception. Smoking reduces placental blood flow, raising low birth weight and SIDS risk.
Pre-conception blood screening (ACOG 2021):
CBC — screen for iron-deficiency anemiathyroid-stimulating hormone: A pituitary hormone that prods the thyroid to work — it rises when the thyroid is underactive. — subclinical hypothyroidism affects embryonic neurodevelopment25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. — supplement if < 50 nmol/LVitamin B12 — required for vegans (low B12 + high folate is the 'folate trap')Rubella / varicella IgG — vaccinate before pregnancy if negativeHIV / syphilis / hepatitis BPeriodontitis screen (severe periodontitis is linked to preterm birth, B-tier evidence)
Chronic-disease stabilization matters far more than supplements:
Diabetes: HbA1c < 6.5%Hypertension: women on ACEi / ARB must switch (contraindicated in pregnancy)Hyperthyroidism / hypothyroidism: stabilize before conceptionDepression / anxiety medications: review safety with psychiatry
Getting the 3 months before conception right beats taking 20 supplements during mid-to-late pregnancy. This is one of the rare nutrition windows where early intervention compounds.
起跑前的三件事
起跑前的 3 件事:1. 女性每天 400-800 μg 叶酸, 孕前 3 个月开始, 持续到孕 12 周。它是预防胎儿神经管缺陷最强的单一干预, 能把风险降 50-70%。有过神经管缺陷孕史、在用抗癫痫药、或有糖尿病的女性可能要加量, 但那是医师开的处方, 不自行加; 单纯体重偏胖不是加量理由 (NICE 2025)。
2. 把体重调进合理区间 (身体质量指数 18.5-23.9)。太胖会把妊娠糖尿病、子痫前期、巨大儿、剖宫产的风险抬高 2-4 倍; 太瘦则容易早产、低出生体重、胎儿长不足。男方胖瘦也影响精子质量和后代代谢 (Salas-Huetos 2017)。
3. 戒烟、限酒, 双方都做。孕期任何量的酒精都可能伤到胎儿 (造成胎儿酒精谱障碍), 世界卫生组织和美国儿科学会都建议孕前 3 个月双方就戒。吸烟会让胎盘供血下降, 抬高低出生体重和婴儿猝死的风险。
孕前检查 · 慢病先稳住
除了这三件, 还有两件事去医院做一次就好: 一是孕前查一轮血 (贫血、甲状腺、维生素 D 和 B12、风疹水痘抗体、乙肝等传染病、以及牙周), 哪项不足提前补齐; 二是把已有的慢病先稳住再怀 (血糖、血压、甲状腺、以及正在吃的抑郁焦虑药), 尤其某些降压药孕期不能用、要提前请医生换掉。这一层具体查哪些、达标值是多少, 交给产检医生, 不用自己背。Natural fertility supplements debunked
'Pre-conception preparation' is a highly commercialized lane; layering it by evidence makes the picture clearer.The few with real RCT evidence:
Folate 400-800 μg — NTD prevention (A-tier)Vitamin D ≥ 600 IU/day — in the deficient, improves birth weight and reduces preterm birth (B-tier)Iodine 150 μg/day (pre-conception) + 250 μg/day (pregnancy) — prevents fetal thyroid dysplasia and cognitive impairment (WHO strong recommendation)Iron-deficiency anemia treatment — supplement iron + co-administered vitamin C when Hb < 110 g/L (Hallberg 1989, WHO 2016)
Mixed evidence:
CoQ10 — for women 35+ and male sperm energetics; small RCTs show improved oocyte quality and sperm motility (Bentov 2014 and others), but sample sizes are small; not first-line, not a scamInositol (myo-inositol + D-chiro) — improves ovulation in PCOS / polycystic women (Teede 2023 PCOS guideline lists it as adjunct); no clear benefit in healthy womenOmega-3 (DHA + EPA) — 200 mg DHA/day during pregnancy is genuinely important for fetal brain; pre-conception evidence is weaker but reasonable
Weak or absent evidence (the majority):
'Pregnancy milk powder': mostly regular milk + DHA + folate; if your regular diet is balanced and you already take folate + calcium separately, this item is unnecessary'Royal jelly' / 'bird's nest': no RCT evidence; royal jelly's hormone-like compounds have triggered allergies — rare case reports of fatal anaphylaxis'Placenta extract' / 'deer-fetus syrup': no RCT data; some contain undeclared exogenous hormonesMale 'fertility' combos (arginine + maca + yohimbine): maca has weak evidence for sperm motility, but the effect is far smaller than quitting smoking, limiting alcohol, or losing weight
Both partners starting 6 months early with exercise, dietary improvement, smoking cessation, weight management, and periodontal treatment — that bundle's effect typically beats every supplement stacked together. This is the counter-intuitive truth in the nutrition story: earlier and more fundamental = more valuable.
hallberg-1989-iron-csalas-huetos-2017-male-fertility
Egg / oocyte timeline · fetal to menopause
Oocyte biology is the opposite of sperm biology — women are born carrying every egg they will ever have. This is the most counter-intuitive and most important fact in this scene.Full timeline:
Fetal week 20 is peak: ovaries contain 6-7 million primary oocytes, the most in a lifetime; from then on numbers only fall as atresia continues throughout lifeBirth: 1-2 million remain (80-90% already lost to atresia)Puberty (menarche): 300-500 thousand, entering cyclic consumptionReproductive years (12-45): each cycle activates 15-20 primordial follicles from the quiescent pool into a growing cohort, but only 1 ovulates (dominant follicle) — the other 14-19 die via atresia; 30 years adds up to ~400-500 ovulations plus 8,000-10,000 atretic lossesAge 35: 100-150 thousand left, decline visibly accelerates, chromosomal aneuploidy rates start to climb (age + meiotic error)Age 40: 20-30 thousand, aneuploidy ~50% (vs ~10% at 30), miscarriage rate sharply up, Down syndrome risk upMenopause (median 51): <1,000 (functional exhaustion); FSH surges, E2 collapses, perimenopausal symptoms appear
This curve tells us several things:
1. Eggs cannot regenerate. Male sperm are continuously produced from spermatogonial stem cells throughout life, but female oocytes have no reserve stem cell pool — one used, one gone. 'Ovarian age' isn't exactly chronological age but tracks it tightly on average.
2. 'Dormant' oocytes are actually frozen mid-meiosis I. Meiosis begins before birth and arrests at prophase I; the monthly 'activation' before ovulation finishes meiosis I and stops again at metaphase II; meiosis II only completes after fertilization. That decades-long pause is a window for DNA damage accumulation and is the chemical root of the high aneuploidy rates seen with maternal age.
3. AMH (Anti-Müllerian Hormone) is the marker of ovarian reserve. Secreted by granulosa cells of small preantral follicles, it reflects how much 'reserve army' remains; unlike FSH, AMH doesn't fluctuate across the cycle and can be measured any day. Reading: in women 20-30, <1.0 ng/mL signals low reserve and deserves attention; 1.0-3.5 ng/mL is normal; >3.5 ng/mL suggests possible PCOS. AMH doesn't directly predict natural conception, but it does predict IVF stimulation response.
4. Oocyte quality matters more than count. Past 35 the issue is rarely 'no eggs left' — it's that the remaining eggs have high aneuploidy rates. Interventions with some RCT signal for quality:
CoQ10 200-600 mg/day — Bentov 2014 and other small trials, mitochondrial functionDHEA 25-75 mg/day — used at some IVF centers (controversial, only in older or diminished-ovarian-reserve (DOR) patients)Inositol — PCOS patientsAdequate vitamin DLimit alcohol, quit smoking, weight management, antioxidant-rich diet (Mediterranean)
5. Egg freezing — the real numbers:
Freeze 15-20 eggs before 35: live-birth rate per round 70-90%Freeze 15-20 at 38: 50-60%Freeze at 40+: 30-40%, more eggs doesn't lift it muchVitrification technology since the 2010s gives ≥90% post-thaw survival — that's no longer the bottleneck
The point: age determines quality; more eggs frozen doesn't fix age.
'Ovarian maintenance' debunked:
'Ovary massage' has no evidence base, and some techniques may damage tissue'Beauty-salon ovarian maintenance' is a commercial gimmick with no medical evidence'Placenta extract / royal jelly / TCM tonics' mostly do nothing, and some contain undeclared hormonesWhat you can actually do: quit smoking, limit alcohol, weight management (PCOS), treat chronic disease, sleep adequately, reduce chemical exposure (BPA, phthalates)
Clinical red flags to take seriously:
Acute pelvic pain that is severe and persistent, with vomiting or syncope, may be ovarian torsion — go to the ER immediatelyEctopic pregnancy: missed period + unilateral abdominal pain + vaginal bleeding + shoulder-tip pain or syncope — also an ER visit; this is one of the avoidable causes of death in women of reproductive age
Atlas reading: menstrual-cycle (HPO + cycle mechanism), perimenopause (E2 withdrawal, KNDy, MHT), PCOS, plus the fertility assessment (AMH) in the report engine.
Sperm timeline · production + WHO params
The sperm story is the opposite of the egg story: men make sperm continuously through life, but quality and quantity quietly decline.Spermatogenesis (an under-taught part of the Atlas):
Spermatogonial stem cells sit at the base of the seminiferous tubules and divide / differentiate throughout lifePathway: type A spermatogonia → type B spermatogonia → primary spermatocyte → meiosis I → secondary spermatocyte → meiosis II → spermatid → spermatozoonFull cycle ~74 days (spermatogonium to mature sperm), then ~12 days in the epididymis to acquire motility and fertilization competenceTotal ~90 days (3 months) — this is why preconception lifestyle changes need a 3-month lead time to show up
Normal fertility parameters (WHO 2010 / 2021):
| Parameter | Lower reference limit |
|---|---|
| Semen volume | ≥ 1.5 mL |
| Total sperm count | ≥ 39 × 10⁶/ejaculate |
| Sperm concentration | ≥ 15 × 10⁶/mL |
| Total motility (PR + NP) | ≥ 40% |
| Progressive motility (PR) | ≥ 32% |
| Normal morphology | ≥ 4% (strict Kruger criteria) |
| Viability | ≥ 58% |
| pH | 7.2-8.0 |
A few notes:
'Normal' is not 'optimal' — a man whose parameters just clear the lower limits can still struggle with natural conception'Normal morphology 4%' sounds low because the 1999 shift to strict Kruger criteria reset the bar — 4% is where most fertile men actually sitSemen analysis has intrinsic variability + sampling effects — do it at least twice, 2-4 weeks apart, and average
salas-huetos-2017-male-fertility
Global decline + age + external causes
The global sperm-decline trend (Levine's two meta-regressions; the 1973-2018 figures below come from the second one, published online in 2022 and in-issue in 2023 — you will see it cited under either year):Western male sperm concentration fell 51% between 1973 and 2018 (from ~100 M/mL to ~49 M/mL)Total sperm count fell 62% over the same windowThe decline is accelerating — steeper after 1990Chinese data point the same way: Huang 2017 in *Fertility and Sterility* tracked semen quality in 30,636 young men from 2001 to 2015Likely drivers: endocrine disruptors (BPA, phthalates), obesity, sedentariness, heat, ultra-processed food
This is one of the largest hidden concerns in global reproductive health.
Male fertility decline with age:
From 35+, sperm DNA fragmentation (DFI) risesFrom 40+, count and motility drift down gentlyFrom 45+, de novo mutation rate rises, and paternal age >45 is mildly associated with autism + schizophrenia risk in offspringA 70-year-old man can still father children — the curve is far flatter than the female curve
Main external causes of sperm damage:
1. Heat: testes need to sit 2-3°C below core temperature; sedentary work, tight underwear, laptop-on-lap, repeated saunas or hot baths raise local temperature and depress production — fix those and parameters recover over ~3 months
2. Smoking: DNA fragmentation up, morphology worse, concentration down; quitting for 3-6 months produces clear improvement
3. Heavy alcohol: suppresses testicular Leydig cells → T down, plus direct toxicity to sperm; limit to ≤7 units/week as a baseline
4. Obesity (BMI > 30): Salas-Huetos 2017 meta shows BMI strongly negatively correlated with sperm parameters; mechanism is fat-tissue aromatization of androgens → E2 ↑ → HPG axis suppressed, plus local testicular heat; even 5-10% weight loss visibly improves parameters
5. Endocrine-disrupting chemicals (EDCs): BPA in plastic bottles, can liners, thermal-receipt paper; phthalates in soft plastics, cosmetics, fragrance; PFAS ('forever chemicals') in non-stick cookware, water-resistant clothing, food packaging; pesticides (glyphosate, organophosphates, pyrethroids) in food residue. Practical: limit plastic, glass food storage, fewer non-stick pans, more organic produce, less processed food
6. Chronic disease: diabetes and hypertension directly and via meds; hypo- or hyperthyroidism via HPG axis; depression and chronic stress via hypothalamic–pituitary–adrenal axis: The body's stress-response chain (hypothalamus → pituitary → adrenal) that releases cortisol. suppressing HPG; OSA via hypoxia and lower T; treating the disease partially restores fertility
salas-huetos-2017-male-fertilitylevine-2017-humupd-sperm-declinelevine-2023-humupd-sperm-decline-globalhuang-2017-fertstert-china-semen
Interventions by RCT tier + cryopreservation
Sperm-quality interventions, by RCT strength:A (strong): quit smoking, weight loss (in obese), moderate (not extreme) exercise, limit alcoholB (moderate): antioxidant cocktails (vit C + E + Zn + Se + CoQ10 + L-carnitine) — Cochrane 2019 review shows partial benefit; omega-3; adequate vitamin DC (weak / mostly commercial): maca with small positive trials, effect much smaller than lifestyle; D-aspartic acid weak signal; ashwagandha with positive small trials (Ambiye 2013); 'male vitality / spermatogenesis' combo formulas heavily marketed, evidence thin
Sperm banking / cryopreservation:
Before chemo or radiation: bank aheadDelaying fatherhood (35+): an option, but since sperm production is continuous, banking isn't as necessary as egg freezingSurvival: modern cryopreservation 60-80%
Atlas reading: andropause (T + LOH), endocrine, microplastics (EDC exposure), alcohol-metabolism, obesity / metabolic-syndrome, ashwagandha (commercial vs evidence).
salas-huetos-2017-male-fertilityambiye-2013-ashwagandha-sperm
Chapter 2
Neural tube · days 21–28
Neural tube · days 21–28
One of the most critical windows in embryonic development is days 21-28 post-fertilization — the time of neural-tube closure. Most women don't yet know they're pregnant at this point, which is the chemical reason behind the rule 'start folate 3 months before'.
The embryology of neural-tube closure:
Days 17-19 post-fertilization: the neural plate forms in the ectodermDays 20-22: the neural plate folds upward into a groove (neural groove)Days 23-26: the groove's edges zip together from the middle outwardBy day 28: closure should be complete, forming the neural tube — the future brain + spinal cord
When folate is insufficient, closure fails, producing neural-tube defects (NTDs):
Anencephaly: failure of cephalic closure; the fetus has no cerebral hemispheres — most are stillborn or die as newbornsSpina bifida: failure of caudal closure; varying degrees of neural damage, with severe cases causing lower-limb paralysis and bowel / bladder incontinenceEncephalocele: skull defect with herniation of brain tissue
Folate's prevention of NTDs is one of modern medicine's strongest public-health wins:
MRC 1991 *Lancet* RCT: in women with prior NTD pregnancies, 4 mg/day folate cut recurrence by 72%Czeizel 1992 *NEJM* RCT: in the general population, 0.8 mg/day reduced first-occurrence NTD to zero (no cases in intervention group, multiple in control)Mechanism: folate → one-carbon metabolism → purine + thymidine synthesis → meets the rapid proliferation rate of neural-tube cells; partly via methylation + homocysteine pathway (see folate / one-carbon L4)
Global public-health progress:
The US has mandated 0.14 mg folate per 100 g of flour since 1998; NTD incidence fell from 1/2,000 to 1/3,000-4,000 (Williams 2015 *MMWR*)80+ countries have mandatory folate fortification: Canada, Chile, Costa Rica, Australia, etc.Most European countries fortify voluntarily, NTD incidence hasn't fallen meaningfully, and policy debate continuesChina has provided free folate (0.4 mg/day) to women of reproductive age since 2009; rural NTD has dropped significantly but urban-rural gaps remain
Click 'Take a closer look' for a 4-step animation of neural-tube closure days 17-28 and the chemical roots of closure failure under folate insufficiency.
The embryology of neural-tube closure:
Days 17-19 post-fertilization: the neural plate forms in the ectodermDays 20-22: the neural plate folds upward into a groove (neural groove)Days 23-26: the groove's edges zip together from the middle outwardBy day 28: closure should be complete, forming the neural tube — the future brain + spinal cord
When folate is insufficient, closure fails, producing neural-tube defects (NTDs):
Anencephaly: failure of cephalic closure; the fetus has no cerebral hemispheres — most are stillborn or die as newbornsSpina bifida: failure of caudal closure; varying degrees of neural damage, with severe cases causing lower-limb paralysis and bowel / bladder incontinenceEncephalocele: skull defect with herniation of brain tissue
Folate's prevention of NTDs is one of modern medicine's strongest public-health wins:
MRC 1991 *Lancet* RCT: in women with prior NTD pregnancies, 4 mg/day folate cut recurrence by 72%Czeizel 1992 *NEJM* RCT: in the general population, 0.8 mg/day reduced first-occurrence NTD to zero (no cases in intervention group, multiple in control)Mechanism: folate → one-carbon metabolism → purine + thymidine synthesis → meets the rapid proliferation rate of neural-tube cells; partly via methylation + homocysteine pathway (see folate / one-carbon L4)
Global public-health progress:
The US has mandated 0.14 mg folate per 100 g of flour since 1998; NTD incidence fell from 1/2,000 to 1/3,000-4,000 (Williams 2015 *MMWR*)80+ countries have mandatory folate fortification: Canada, Chile, Costa Rica, Australia, etc.Most European countries fortify voluntarily, NTD incidence hasn't fallen meaningfully, and policy debate continuesChina has provided free folate (0.4 mg/day) to women of reproductive age since 2009; rural NTD has dropped significantly but urban-rural gaps remain
Click 'Take a closer look' for a 4-step animation of neural-tube closure days 17-28 and the chemical roots of closure failure under folate insufficiency.
神经管闭合的胚胎学
胚胎发育最关键的窗口之一发生在受精后 21-28 天, 也就是神经管闭合的时间。神经管闭合的胚胎学:
受精后 17-19 天: 神经板 (neural plate) 在外胚层形成20-22 天: 神经板向上折成沟 (neural groove)23-26 天: 沟边缘合拢, 从中段向两端拉链式闭合28 天前: 应该全部闭合形成神经管, 后续发育为脑加脊髓
叶酸不足时闭合失败, 就出现神经管缺陷 (NTD):
无脑儿 (anencephaly): 头端闭合失败, 胎儿无脑半球, 多死产或新生儿死亡脊柱裂 (spina bifida): 尾端闭合失败, 不同程度的神经损伤, 严重者下肢瘫加大小便失禁脑膨出 (encephalocele): 颅骨缺损, 脑组织疝出
两个改变了公共卫生的 RCT
叶酸预防 NTD 是现代医学最强公共卫生胜利之一:MRC 1991 Lancet RCT: 既往 NTD 史的女性补充 4 mg/天叶酸, 复发 NTD 降 72%Czeizel 1992 NEJM RCT: 一般人群 0.8 mg/天, 首次 NTD 降到 0 (干预组无病例, 对照组有多例)机制: 叶酸 → 一碳代谢 → 嘌呤和胸腺嘧啶合成 → 满足神经管细胞增殖速率需求; 部分通过甲基化和同型半胱氨酸通路 (见 folate/one-carbon L4)
强化面粉这场全球实验
全球公共卫生进展:美国 1998 起强制面粉强化 0.14 mg 叶酸/100 g, NTD 发生率从 1/2000 降到 1/3000-4000 (Williams 2015 MMWR)加拿大、智利、哥斯达黎加、澳大利亚等 80 多个国家强制叶酸强化欧洲多数国家自愿强化, NTD 发生率没明显降, 政策辩论持续中国 2009 起广泛免费派发叶酸 (0.4 mg/天) 给育龄妇女, 农村 NTD 下降显著但城乡差距仍存在
Folate trap, MTHFR, controversies
The folate story is more complex than the public realizes; a few common controversies need unpacking.Controversy 1: the folate trap
Large unmetabolized folic acid (UMFA) accumulating in plasma at high doses is a real phenomenon, but the clinical consequence evidence is mixedThe real concern is 'masking B12 deficiency': folate corrects megaloblastic anemia, but neurological damage continues to progress — eventually irreversiblySolution: vegans, the elderly, and people with low gastric acid must check B12 alongside folate
Controversy 2: MTHFR gene testing
The MTHFR C677T polymorphism reduces enzyme activity — most in TT homozygotes, moderately in CT heterozygotes. How common it is varies sharply by ancestry: NIH ODS puts TT homozygosity at ~25% of Hispanics, ~10% of Caucasians and Asians, and ~1% of African AmericansThe commercial line 'MTHFR test → must take 5-MTHF (active folate)' is over-extensionReality: standard 400 μg folic acid still prevents NTDs in TT individuals — adequate quantity is what matters5-MTHF (Quatrefolic / Metafolin) costs 2-3× more, with marginal added clinical benefit; combining it with TMG (see tmg-betaine story) is a reasonable scenario
Controversy 3: 'folate overload' from fortified foods
Concern: in the US, exposure from fortified staples + personal supplements may exceed 1 mg/dayOne concern: masking B12 deficiency in the elderly — CDC and IOM are monitoringAnother: relation to colon or prostate cancer — large cohorts show no clear effect, but it's an active research areaConsensus: for women of reproductive age, benefit far exceeds potential risk; fortification policy has been stable for 30+ years
Operational summary:
All women trying to conceive / in early pregnancy: 0.4-0.8 mg/day folate; a multivitamin containing B12 + B6 is a reasonable choiceThe original CDC 1992 text pairs the 0.4 mg figure with a ceiling: keep total folate intake below 1 mg/day except under the supervision of a physician — precisely because of the B12 masking problem in Controversy 1The RCT evidence for 4 mg/day comes only from women with a prior NTD-affected pregnancy (MRC 1991). The CDC text leaves that decision to a physician and notes 0.4 mg may be equally effective. This is not a dose to escalate to on your ownAntiepileptic drugs, or type 1 / type 2 diabetes: NICE 2025 offers a high dose for these two groups, but it is initiated by an obstetrician or neurologist, not by the readerA raised BMI is not by itself a reason to increase the dose: NICE 2025 reviewed the evidence and states 400 μg is sufficient unless another risk factor above appliesMTHFR genotype is not a reason to increase the dose: at 400 μg/day the red-cell folate dose-response is near-identical across genotypes (Crider 2022), and ACMG does not recommend routine testingMen also supplementing folate has evidence for improving sperm DNA integrity (Salas-Huetos 2017)Don't agonize over 'natural vs synthetic' — synthetic folic acid has the strongest NTD-prevention RCT evidence; dietary folate (5-MTHF) is just as good, but hitting 400-800 μg from food alone is hard
czeizel-1992-folatewilliams-2015-ntd-fortificationcrider-2022-folic-acid-30-yearsnice-ng247-2025-maternal-nutritionacmg-mthfr-2013nih-ods-folateliew-2015-mthfr
Chapter 3
Pregnancy iron · doubled
Pregnancy iron · doubled
Pregnancy is the stage of life with the highest iron requirement in healthy adult women — mid-to-late pregnancy EAR rises from ~18 mg/day to ~27 mg/day (China DRI), double that of non-pregnant women and 4× that of same-age men.
The spike comes from five pulls on iron:
1. Fetal iron storage: a full-term newborn has ~270-300 mg of iron stored in the liver to support the 4-6 months until solid foods begin — all of it from the mother
2. Placenta + umbilical cord: ~90 mg of iron
3. Maternal blood volume rises 45-50%: red cell mass also increases, but plasma rises more, producing 'physiological dilution'
4. Delivery blood loss: ~500 mL for vaginal delivery, ~1,000 mL for C-section
5. Lactation: breast milk is low in iron (~0.3 mg/L), but lactation delays return of menses, cutting period blood loss
WHO 2016 recommendations:
Routine 30-60 mg/day iron + 0.4 mg/day folate throughout pregnancyIron-deficient regions or anemia-endemic areas: daily supplementationIron-adequate or screening-normal regions: intermittent supplementation (3×/week) is also effective
The cost of pregnancy iron-deficiency anemia:
Maternal: fatigue, elevated risk of intrapartum and postpartum hemorrhageFetal: preterm birth, low birth weight, cognitive delay in infancy (iron is critical for infant myelination; long-term IQ averages 1-2 points lower — irreversible)The reverse is also a problem: maternal over-iron (Hb > 130 g/L) is linked to fetal growth restriction — not 'more is better'
Practical pitfalls of iron supplementation:
Form: ferrous sulfate / fumarate (Fe²⁺) > ferrous gluconate; polysaccharide-iron complexes are weaker; newer ferric maltol has fewer side effectsEmpty stomach gives the best absorption but more GI irritation; alternate-day dosing (Stoffel 2017) gives higher total absorption in healthy mildly-deficient individuals because daily dosing suppresses hepcidin (see iron / gut L4), and alternate days let hepcidin resetCo-administer with vitamin C: 50-100 mg vitamin C increases non-heme iron absorption 2-4× (see vitamin-c / iron L4)Avoid simultaneous calcium, tea, coffee, milk, or antacids — separate by at least 2 hoursSide effects: constipation, dark stools, GI upset; can halve the dose, switch forms, or, for persistent issues, consider IV ironSevere deficiency (Hb < 90 g/L) is hard to correct orally; usually directly treated with IV iron (ferric carboxymaltose)
On 'pregnancy tea / bird's nest / Ejiao for blood': Ejiao is traditionally said in TCM to 'tonify blood', but its actual iron content is very low (~0.2 mg/g dry); from a modern perspective, pork liver, beef, clams, and fortified grains contain 10-100× more iron than Ejiao.
The spike comes from five pulls on iron:
1. Fetal iron storage: a full-term newborn has ~270-300 mg of iron stored in the liver to support the 4-6 months until solid foods begin — all of it from the mother
2. Placenta + umbilical cord: ~90 mg of iron
3. Maternal blood volume rises 45-50%: red cell mass also increases, but plasma rises more, producing 'physiological dilution'
4. Delivery blood loss: ~500 mL for vaginal delivery, ~1,000 mL for C-section
5. Lactation: breast milk is low in iron (~0.3 mg/L), but lactation delays return of menses, cutting period blood loss
WHO 2016 recommendations:
Routine 30-60 mg/day iron + 0.4 mg/day folate throughout pregnancyIron-deficient regions or anemia-endemic areas: daily supplementationIron-adequate or screening-normal regions: intermittent supplementation (3×/week) is also effective
The cost of pregnancy iron-deficiency anemia:
Maternal: fatigue, elevated risk of intrapartum and postpartum hemorrhageFetal: preterm birth, low birth weight, cognitive delay in infancy (iron is critical for infant myelination; long-term IQ averages 1-2 points lower — irreversible)The reverse is also a problem: maternal over-iron (Hb > 130 g/L) is linked to fetal growth restriction — not 'more is better'
Practical pitfalls of iron supplementation:
Form: ferrous sulfate / fumarate (Fe²⁺) > ferrous gluconate; polysaccharide-iron complexes are weaker; newer ferric maltol has fewer side effectsEmpty stomach gives the best absorption but more GI irritation; alternate-day dosing (Stoffel 2017) gives higher total absorption in healthy mildly-deficient individuals because daily dosing suppresses hepcidin (see iron / gut L4), and alternate days let hepcidin resetCo-administer with vitamin C: 50-100 mg vitamin C increases non-heme iron absorption 2-4× (see vitamin-c / iron L4)Avoid simultaneous calcium, tea, coffee, milk, or antacids — separate by at least 2 hoursSide effects: constipation, dark stools, GI upset; can halve the dose, switch forms, or, for persistent issues, consider IV ironSevere deficiency (Hb < 90 g/L) is hard to correct orally; usually directly treated with IV iron (ferric carboxymaltose)
On 'pregnancy tea / bird's nest / Ejiao for blood': Ejiao is traditionally said in TCM to 'tonify blood', but its actual iron content is very low (~0.2 mg/g dry); from a modern perspective, pork liver, beef, clams, and fortified grains contain 10-100× more iron than Ejiao.
需求为什么会翻倍
孕期是健康成年女性铁需求最高的阶段——孕中后期 EAR 从约 18 mg/天升至约 27 mg/天 (中国 DRI), 比未孕女性翻倍, 比同龄男性高 4 倍。为什么需求飙升, 主要是 5 件事在拉:
1. 胎儿铁储备: 足月新生儿约 270-300 mg 铁储在肝, 用来支持出生后 4-6 个月到辅食阶段; 这部分全部来自母体
2. 胎盘加脐带: 约 90 mg 铁
3. 母体血容量上升 45-50%: 红细胞质量也增加, 但血浆增得更多, 出现生理性稀释
4. 分娩失血: 阴道分娩约 500 mL 血, 剖宫产约 1000 mL
5. 哺乳期: 母乳含铁不高 (约 0.3 mg/L), 但哺乳推迟月经回潮, 减少经期铁丢失
补多少 · 缺了要付什么代价
WHO 2016 推荐:孕期常规补铁 30-60 mg/天加叶酸 0.4 mg/天, 持续整个孕期缺铁地区或贫血流行区: 每日补铁充足或检测正常区: 间断补 (每周 3 次) 也有效
孕期缺铁性贫血的代价:
母体方面: 疲劳, 产时和产后大出血风险升胎儿方面: 早产、低出生体重, 婴幼儿期认知发育延迟 (铁是婴幼儿髓鞘形成的核心, 长期跟踪 IQ 平均低 1-2 分, 不可逆)反向也有问题: 母体过度补铁 (Hb > 130 g/L) 与胎儿生长受限相关, 不是越多越好
补铁的实操坑
补铁的实操坑:形式选择上: 硫酸亚铁、富马酸亚铁 (Fe²⁺) 比葡萄糖酸亚铁好, 多糖铁复合物稍弱; 新型 ferric maltol 副作用少空腹吸收最好但胃刺激大; 隔日补法 (Stoffel 2017) 在健康轻度缺铁人群中总吸收量更高, 因为每日补会抑制 hepcidin (见 iron/gut L4), 隔日让 hepcidin 有时间重置与 vit C 同服: 50-100 mg vit C 提高非血红素铁吸收 2-4 倍 (见 vitamin-c/iron L4)避免与钙、茶、咖啡、奶、抗酸药同服, 至少间隔 2 小时副作用: 便秘、黑便、胃部不适; 可减半剂量或换形式, 持续问题考虑静脉铁剂重度缺铁 (Hb < 90 g/L) 口服难补足, 通常直接用静脉铁剂 (羧基麦芽糖铁 ferric carboxymaltose) 一次性纠正
阿胶补血站不站得住
关于孕期茶、燕窝、阿胶补血: 阿胶在中医语境里被认为补血, 但实际铁含量很低 (约 0.2 mg/g 干品); 现代视角下, 猪肝、牛肉、蛤蜊、强化谷物的含铁量比阿胶高 10-100 倍。Chapter 4
DHA · fetal brain
DHA · fetal brain
Fetal brain and retina go through a DHA-demand surge from mid-to-late pregnancy through the first 2 years postpartum: fetal gray matter (dry weight) is ~15-20% DHA, and the retina is ~50% DHA. All of this DHA must come from maternal blood — the fetus has very low ALA → DHA conversion capacity (< 1%).
ACOG / WHO / FAO recommendation (pregnancy + lactation): DHA + EPA ≥ 200-300 mg/day, achievable with 2-3 servings of low-mercury fish per week; DHA alone ≥ 200 mg/day is a stable target.
Fish is the best source, but mercury is a real concern. Per the FDA + EPA 2021 classification:
Best choices (2-3 servings/week, ~100 g each): cod, salmon, sardines, anchovies, trout, tilapia, haddock, Atlantic mackerel — these are low-mercury and high-DHA, ideal for pregnancyGood choices (1 serving/week): black sea bass, carp, Atlantic croaker, flounder, hakeAvoid (high mercury): shark, swordfish, bigeye tuna, tilefish (Gulf of Mexico), king mackerel, marlin, Atlantic orange roughy; limit canned tuna (especially albacore)
The mercury-vs-DHA balance: Hibbeln 2007 *Lancet* ALSPAC study followed 12,000 UK mother-baby pairs — children of mothers eating < 340 g/week (12 oz, the FDA's prior upper limit) had significantly lower verbal IQ. This challenged the older 'pregnant women should eat less fish' advice and led FDA to revise its 2014 / 2021 guidance to encourage fish rather than simply avoid it. The consensus: the DHA shortfall from not eating fish causes more harm than the mercury exposure from moderate intake of low-mercury fish.
Fish oil vs real fish:
Real fish > fish oil: also provides protein, selenium, iodine, vitamin D, and an intact lipid matrixFor pregnant women who don't eat fish: fish oil + algae-derived DHA is a reasonable substitute; algae DHA (vegan) is increasingly preferred, with zero mercuryInfant formulas now also add DHA + ARA; RCT evidence is mixed (Cochrane 2017 meta on cognitive and visual outcomes)
Marketing traps for 'pregnancy DHA gummies / high-concentration DHA':
Most DHA gummies have 200-250 mg/dose; eating fish twice a week already covers ~100%Ultra-high doses (1,000+ mg) provide no extra fetal benefit and raise bleeding risk at delivery (omega-3 inhibits platelets)'EPA boosts mood' and 'DHA makes your baby smarter' are over-marketed — the real evidence is for sufficiency, not megadosing
ACOG / WHO / FAO recommendation (pregnancy + lactation): DHA + EPA ≥ 200-300 mg/day, achievable with 2-3 servings of low-mercury fish per week; DHA alone ≥ 200 mg/day is a stable target.
Fish is the best source, but mercury is a real concern. Per the FDA + EPA 2021 classification:
Best choices (2-3 servings/week, ~100 g each): cod, salmon, sardines, anchovies, trout, tilapia, haddock, Atlantic mackerel — these are low-mercury and high-DHA, ideal for pregnancyGood choices (1 serving/week): black sea bass, carp, Atlantic croaker, flounder, hakeAvoid (high mercury): shark, swordfish, bigeye tuna, tilefish (Gulf of Mexico), king mackerel, marlin, Atlantic orange roughy; limit canned tuna (especially albacore)
The mercury-vs-DHA balance: Hibbeln 2007 *Lancet* ALSPAC study followed 12,000 UK mother-baby pairs — children of mothers eating < 340 g/week (12 oz, the FDA's prior upper limit) had significantly lower verbal IQ. This challenged the older 'pregnant women should eat less fish' advice and led FDA to revise its 2014 / 2021 guidance to encourage fish rather than simply avoid it. The consensus: the DHA shortfall from not eating fish causes more harm than the mercury exposure from moderate intake of low-mercury fish.
Fish oil vs real fish:
Real fish > fish oil: also provides protein, selenium, iodine, vitamin D, and an intact lipid matrixFor pregnant women who don't eat fish: fish oil + algae-derived DHA is a reasonable substitute; algae DHA (vegan) is increasingly preferred, with zero mercuryInfant formulas now also add DHA + ARA; RCT evidence is mixed (Cochrane 2017 meta on cognitive and visual outcomes)
Marketing traps for 'pregnancy DHA gummies / high-concentration DHA':
Most DHA gummies have 200-250 mg/dose; eating fish twice a week already covers ~100%Ultra-high doses (1,000+ mg) provide no extra fetal benefit and raise bleeding risk at delivery (omega-3 inhibits platelets)'EPA boosts mood' and 'DHA makes your baby smarter' are over-marketed — the real evidence is for sufficiency, not megadosing
为什么必须从妈妈血里来
胎儿脑和视网膜在孕中后期到出生后 2 年是 DHA 需求暴涨期: 胎儿脑灰质 (干重) 约 15-20% 是 DHA, 视网膜约 50% 是 DHA。这些 DHA 必须来自母亲血液, 胎儿自身合成能力极低 (ALA → DHA 转换率 < 1%)。ACOG / WHO / FAO 推荐 (孕期加哺乳期): DHA + EPA ≥ 200-300 mg/天, 一周 2-3 份低汞鱼足以达到; DHA 单独 ≥ 200 mg/天是个比较稳的目标。
哪些鱼放心吃 · 哪些要躲开
鱼是最好的来源, 但有汞 (mercury) 风险。按 FDA 加 EPA 2021 分级:最佳选择 (每周可吃 2-3 份, 每份约 100 g): 鳕鱼 (cod)、三文鱼、沙丁鱼、凤尾鱼、鳟鱼、罗非鱼、黑线鳕、大西洋鲭鱼——这些低汞加高 DHA, 是孕期的理想选择。
好选择 (每周 1 份): 黑鲈、鲤鱼、大西洋黄花鱼、比目鱼、鳕鳘。
避免 (汞高): 鲨鱼、剑鱼、大眼金枪鱼、方头鱼 (墨西哥湾)、王鲭、旗鱼、大西洋胸棘鲷; 限制金枪鱼 (尤其大眼), 罐头白金枪鱼可以, 但要有量限。
汞与 DHA 的平衡 · 鱼油还是真鱼
汞 vs DHA 的平衡: Hibbeln 2007 Lancet ALSPAC 研究跟踪 12,000 名英国母婴, 母亲孕期吃鱼 < 340 g/周 (12 oz, FDA 当时上限) 的子女, 口语 IQ 显著较低。这个研究挑战了孕妇吃鱼越少越好的旧建议, 让 FDA 在 2014/2021 修订指南鼓励吃鱼而不是简单回避。共识是: 不吃鱼带来的 DHA 不足损失, 比适量吃低汞鱼带来的汞暴露更大。鱼油 vs 真鱼:
真鱼比鱼油好: 同时提供蛋白、硒、碘、维 D 和完整脂肪基质不吃鱼的孕妇: 鱼油加藻油 DHA 是合理替代, 藻油 (vegan DHA) 更受推崇, 汞含量为 0儿童和婴儿配方也开始添加 DHA 加 ARA, 有 RCT 证据 (Cochrane 2017 meta 在认知和视力终点上结果混杂)
软糖与高浓度的营销陷阱
孕期 DHA 软糖、高浓度补充的营销陷阱:多数 DHA 软糖标 200-250 mg/粒, 一周 2 次鱼基本就 100% 覆盖超高剂量 (1000+ mg) 没有额外胎儿获益, 反而增加产时出血风险 (omega-3 抑制血小板)EPA 增加情绪加DHA 让宝宝聪明都是被过度营销的说法——真实证据是充足而非超量
Chapter 5
Menopause + male T
Menopause + male T
Female menopause (45-55) and male androgen decline (~1%/year from age 35) together form the most hormone-nutrition-dense stage of life.
Female menopause
The core change is the decline of ovarian function: post-menopausal estrogen drops ~90%, and progesterone also falls, triggering a cascade of downstream changes:
Accelerated bone loss — estrogen protects osteoblasts; after withdrawal, osteoclasts lose suppression and bone density can drop ~20% over 5-10 years (see calcium / bone-deposit L4)Rising cardiovascular risk — estrogen had been protecting the endothelium and LDLMetabolic-syndrome risk — visceral fat accumulation + insulin resistanceGenitourinary atrophy — vaginal dryness + recurrent urinary tract infectionsVasomotor symptoms — hot flashes, night sweats, insomnia (70-80% of women, average duration 7 years)Mood fluctuations + cognitive complaints — estrogen receptors are widely distributed in the brain
Evidence-based nutrition + lifestyle interventions:
Calcium 1,200 mg/day + vitamin D 800-1,000 IU + K2 100-180 μg/day: synergy on bone loss (see the calcium, vitamin-k2, vitamin-d stories)Resistance training 2-3×/week: stronger than any supplement at reducing bone lossSoy isoflavones: the Cochrane review (Lethaby 2013) found no conclusive evidence that phytoestrogen supplements reduce hot-flush frequency or severity. The one signal worth watching is concentrated genistein above 30 mg/day, which reduced flush frequency in 4 trials — but those 4 were not pooled, and the reviewers called for further study rather than declaring an effect. Treat soy isoflavones as unproven for flushes, not as a gentler HRTLimit alcohol + quit smoking: both accelerate bone loss
The truth about HRT (hormone replacement therapy): the WHI 2002 (Rossouw, *JAMA*) large RCT caused HRT use to collapse, but the study population skewed older (mean age 63) — well past the menopause window. Modern consensus (NAMS 2022): for women within 10 years of menopause, < 60 years old, with moderate-to-severe symptoms, HRT's benefit exceeds its risk. Not 'lifelong contraindication' — it's a window-of-opportunity + individualization question.
Male androgen decline (some people call it andropause — not entirely accurate)
Total testosterone declines ~1%/year from age 35; by 65 the average cumulative drop is ~30%'Low T' ≠ 'symptomatic low T' — most older men's T decline is slow and many remain in the lower half of the normal range; symptoms often stem from obesity, low mood, and chronic disease rather than T itselfOnly true symptomatic primary or secondary hypogonadism has a medical indication for T replacement
Real nutrition / lifestyle levers for male T (by effect size):
1. Weight loss + strength training — in the EMAS cohort, losing weight came with a proportional rise in testosterone, and gaining weight with a proportional fall (Camacho 2013); the single strongest lever. No percentage is given here on purpose: the often-quoted '+20-30% going from BMI 30 to 25' is not a figure that paper publishes
2. Sleep 7-8 hours — one week of sleep deprivation drops T 10-15%
3. Quit smoking + limit alcohol
4. Adequate zinc (see zinc story) — deficiency does lower T, but supplementing in already-replete men doesn't further raise it
5. Adequate vitamin D — some studies show benefit in deficient men; meta-analyses are weak
6. 'Natural T boosters' — D-aspartic acid, fenugreek, Tribulus, deer-horn velvet — mostly weak or unreplicated RCTs
'Male menopause supplements' is one of the most over-marketed product categories. The real levers for T are weight, sleep, exercise, and quitting — not supplements.
Female menopause
The core change is the decline of ovarian function: post-menopausal estrogen drops ~90%, and progesterone also falls, triggering a cascade of downstream changes:
Accelerated bone loss — estrogen protects osteoblasts; after withdrawal, osteoclasts lose suppression and bone density can drop ~20% over 5-10 years (see calcium / bone-deposit L4)Rising cardiovascular risk — estrogen had been protecting the endothelium and LDLMetabolic-syndrome risk — visceral fat accumulation + insulin resistanceGenitourinary atrophy — vaginal dryness + recurrent urinary tract infectionsVasomotor symptoms — hot flashes, night sweats, insomnia (70-80% of women, average duration 7 years)Mood fluctuations + cognitive complaints — estrogen receptors are widely distributed in the brain
Evidence-based nutrition + lifestyle interventions:
Calcium 1,200 mg/day + vitamin D 800-1,000 IU + K2 100-180 μg/day: synergy on bone loss (see the calcium, vitamin-k2, vitamin-d stories)Resistance training 2-3×/week: stronger than any supplement at reducing bone lossSoy isoflavones: the Cochrane review (Lethaby 2013) found no conclusive evidence that phytoestrogen supplements reduce hot-flush frequency or severity. The one signal worth watching is concentrated genistein above 30 mg/day, which reduced flush frequency in 4 trials — but those 4 were not pooled, and the reviewers called for further study rather than declaring an effect. Treat soy isoflavones as unproven for flushes, not as a gentler HRTLimit alcohol + quit smoking: both accelerate bone loss
The truth about HRT (hormone replacement therapy): the WHI 2002 (Rossouw, *JAMA*) large RCT caused HRT use to collapse, but the study population skewed older (mean age 63) — well past the menopause window. Modern consensus (NAMS 2022): for women within 10 years of menopause, < 60 years old, with moderate-to-severe symptoms, HRT's benefit exceeds its risk. Not 'lifelong contraindication' — it's a window-of-opportunity + individualization question.
Male androgen decline (some people call it andropause — not entirely accurate)
Total testosterone declines ~1%/year from age 35; by 65 the average cumulative drop is ~30%'Low T' ≠ 'symptomatic low T' — most older men's T decline is slow and many remain in the lower half of the normal range; symptoms often stem from obesity, low mood, and chronic disease rather than T itselfOnly true symptomatic primary or secondary hypogonadism has a medical indication for T replacement
Real nutrition / lifestyle levers for male T (by effect size):
1. Weight loss + strength training — in the EMAS cohort, losing weight came with a proportional rise in testosterone, and gaining weight with a proportional fall (Camacho 2013); the single strongest lever. No percentage is given here on purpose: the often-quoted '+20-30% going from BMI 30 to 25' is not a figure that paper publishes
2. Sleep 7-8 hours — one week of sleep deprivation drops T 10-15%
3. Quit smoking + limit alcohol
4. Adequate zinc (see zinc story) — deficiency does lower T, but supplementing in already-replete men doesn't further raise it
5. Adequate vitamin D — some studies show benefit in deficient men; meta-analyses are weak
6. 'Natural T boosters' — D-aspartic acid, fenugreek, Tribulus, deer-horn velvet — mostly weak or unreplicated RCTs
'Male menopause supplements' is one of the most over-marketed product categories. The real levers for T are weight, sleep, exercise, and quitting — not supplements.
女性 · 雌激素退场后的连锁
女性更年期 (45-55 岁) 加男性雄激素下降 (35 岁起每年 -1%), 是激素与营养交汇最密集的人生阶段。女性更年期
核心变化是卵巢功能衰退, 雌激素绝经后下降 90%, 加上孕激素下降, 引发一系列下游变化:
骨流失加速——雌激素保护成骨细胞, 缺失后破骨细胞失去抑制, 5-10 年内骨密度可丢约 20% (见 calcium/bone-deposit L4)心血管风险上升——雌激素之前在保护内皮和 LDL代谢综合征风险——内脏脂肪加胰岛素抵抗泌尿生殖系统萎缩——阴道干燥加反复尿路感染血管舒缩症状——潮热、盗汗、失眠 (约 70-80% 女性经历, 平均持续 7 年)情绪波动加认知抱怨——雌激素受体在大脑分布很广
有循证的营养与训练
有循证的营养加生活干预:钙 1200 mg/天 + 维 D 800-1000 IU + K2 100-180 μg/天: 骨流失协同 (见 calcium、vitamin-k2、vitamin-d 故事)抗阻训练每周 2-3 次, 比任何补剂都更能减骨流失大豆异黄酮: Cochrane 那篇综述 (Lethaby 2013) 的结论是没有确凿证据说植物雌激素能减少潮热的频率或严重度。唯一值得盯的信号是高剂量染料木黄酮 (> 30 mg/天), 在 4 项试验里确实降低了潮热频率 —— 但那 4 项没有被合并统计, 作者的措辞是值得进一步研究, 不是有效。所以它是未证实, 不是温和版 HRT限酒、戒烟, 都会加速骨流失
HRT 的真相 · 窗口期
HRT (激素替代治疗) 的真相: WHI 2002 Rossouw JAMA 这个大型 RCT 让 HRT 使用骤降, 但当时研究人群偏大 (平均 63 岁), 已远离绝经窗口。现代共识 (NAMS 2022) 认为: 绝经后 10 年内、< 60 岁开始、有中度到重度症状的女性, HRT 获益大于风险——不是激素终身禁忌, 而是窗口期加个体化。男性 · 睾酮的缓坡
男性雄激素下降 (部分人叫 andropause, 不完全准确)35 岁起总睾酮每年下降约 1%, 平均到 65 岁累计 -30%低 T不等于症状性低 T——大多数老年男性的 T 下降是缓慢的, 多数仍在正常范围下半段; 症状常常是肥胖、情绪低落、慢病造成的, 不是 T 本身只有真正症状性原发性或继发性性腺功能减退才有医学补 T 指征
真能抬睾酮的杠杆
男性 T 的真营养杠杆 (按效力排序):1. 减重加力量训练——EMAS 队列里, 体重下降伴随睾酮成比例上升, 体重上升则成比例下降 (Camacho 2013), 这是最强的单一杠杆。这里故意不给百分比: 常被引用的BMI 从 30 降到 25 升 20-30%并不是那篇论文给出的数
2. 睡眠 7-8 h——睡眠剥夺 1 周, T 下降 10-15%
3. 戒烟加限酒
4. 锌充足 (见 zinc 故事)——缺锌确实降 T, 但充足者补锌不能进一步升
5. 维 D 充足——一些研究显示缺乏者补充能改善 T, meta 分析较弱
6. 天然睾酮促进剂——D-天冬氨酸、葫芦巴、Tribulus、鹿茸等, 大多 RCT 证据弱或没能复现
男性更年期保健品是被严重夸大的营销品类之一。真正能改变 T 的是体重、睡眠、运动和戒烟, 不是补剂。
Chapter 6
Fertility · the timeline you don't see
Fertility · the timeline you don't see
The physiological curve of fertility — the hard data Chinese-language society talks about least but should learn earliest.
Female natural conception probability (per menstrual cycle):
20-24 years: ~25-30%30 years: ~20%35 years: ~15%38 years: ~10%40 years: ~5%42 years: ~3%45 years: < 2%
The underlying cause: women are born with ~1-2 million oocytes; by puberty this drops to ~300,000; each menstrual cycle consumes ~1,000 (only 1 ovulates; the rest undergo apoptosis). By age 40, ~20-30 thousand remain — and the issue isn't just quantity: the chromosomal aneuploidy rate rises from < 10% at 30 to ~50% at 40, which is the chemical root of the rising miscarriage and Down syndrome risks with maternal age.
Male fertility decline is gentler but equally real:
After age 35, sperm DNA fragmentation risesDe novo mutation rate rises (paternal-age contribution); paternal age > 45 is mildly associated with autism + schizophrenia risk in offspringBut men can still conceive at age 70 — the quantity curve is far flatter than the female curve
The reality of assisted reproductive technology (ART):
IVF (in-vitro fertilization) single-cycle live-birth rate:
< 35 years: ~35-40%35-37 years: ~30%38-40 years: ~20%41-42 years: ~10%> 42 years (own eggs): ~3-5%
'ART compensates for age' is a common misconception. ART improves per-cycle efficiency but cannot reverse oocyte-quality decline. Egg freezing (social) is best before age 34; after 38, both retrieved egg count and downstream IVF success rates drop significantly. PGT-A (preimplantation genetic testing for aneuploidies) improves per-transfer success rates, but doesn't create good embryos out of thin air.
Practical principles (a regret-reducing checklist):
If you want children, do at least one fertility assessment before age 30 (AMH + baseline antral follicle count) — not as pressure, but as decision information< 35 and trying to conceive: if 6 months of attempts haven't worked, see an infertility clinic (the standard is 1 year, shortened to 6 months for 35+)Uncertain when to have children: consult reproductive endocrinology about egg freezing; deciding early beats deciding lateMen 35-45: also worth a semen analysis + DNA fragmentation test — it isn't only 'the woman's issue'Chronic disease or long-term medication: consult on pregnancy risks beforehand
Social-level facts:
The costs of late childbearing: infertility-treatment financial burden, chromosomal-abnormality risk, advanced-age pregnancy complicationsThe costs of early childbearing: career, finances, marital readinessThere is no 'right age', but transparent information lets people choose actively rather than learn only in retrospect
The core message of this scene: the 'biological clock' isn't patriarchal anxiety talk — it's real chemistry. But it isn't destiny either; early knowledge + early assessment + early decision expand the range of choices within biological constraints.
Female natural conception probability (per menstrual cycle):
20-24 years: ~25-30%30 years: ~20%35 years: ~15%38 years: ~10%40 years: ~5%42 years: ~3%45 years: < 2%
The underlying cause: women are born with ~1-2 million oocytes; by puberty this drops to ~300,000; each menstrual cycle consumes ~1,000 (only 1 ovulates; the rest undergo apoptosis). By age 40, ~20-30 thousand remain — and the issue isn't just quantity: the chromosomal aneuploidy rate rises from < 10% at 30 to ~50% at 40, which is the chemical root of the rising miscarriage and Down syndrome risks with maternal age.
Male fertility decline is gentler but equally real:
After age 35, sperm DNA fragmentation risesDe novo mutation rate rises (paternal-age contribution); paternal age > 45 is mildly associated with autism + schizophrenia risk in offspringBut men can still conceive at age 70 — the quantity curve is far flatter than the female curve
The reality of assisted reproductive technology (ART):
IVF (in-vitro fertilization) single-cycle live-birth rate:
< 35 years: ~35-40%35-37 years: ~30%38-40 years: ~20%41-42 years: ~10%> 42 years (own eggs): ~3-5%
'ART compensates for age' is a common misconception. ART improves per-cycle efficiency but cannot reverse oocyte-quality decline. Egg freezing (social) is best before age 34; after 38, both retrieved egg count and downstream IVF success rates drop significantly. PGT-A (preimplantation genetic testing for aneuploidies) improves per-transfer success rates, but doesn't create good embryos out of thin air.
Practical principles (a regret-reducing checklist):
If you want children, do at least one fertility assessment before age 30 (AMH + baseline antral follicle count) — not as pressure, but as decision information< 35 and trying to conceive: if 6 months of attempts haven't worked, see an infertility clinic (the standard is 1 year, shortened to 6 months for 35+)Uncertain when to have children: consult reproductive endocrinology about egg freezing; deciding early beats deciding lateMen 35-45: also worth a semen analysis + DNA fragmentation test — it isn't only 'the woman's issue'Chronic disease or long-term medication: consult on pregnancy risks beforehand
Social-level facts:
The costs of late childbearing: infertility-treatment financial burden, chromosomal-abnormality risk, advanced-age pregnancy complicationsThe costs of early childbearing: career, finances, marital readinessThere is no 'right age', but transparent information lets people choose actively rather than learn only in retrospect
The core message of this scene: the 'biological clock' isn't patriarchal anxiety talk — it's real chemistry. But it isn't destiny either; early knowledge + early assessment + early decision expand the range of choices within biological constraints.
每个周期的自然受孕概率
生育能力的生理曲线——这是中文社会讨论度低, 但应该早讲的硬数据。女性自然受孕概率 (每个月经周期):
20-24 岁: 约 25-30%30 岁: 约 20%35 岁: 约 15%38 岁: 约 10%40 岁: 约 5%42 岁: 约 3%45 岁: < 2%
根本原因是: 女性出生时携带约 100-200 万卵母细胞, 青春期前降到约 30 万, 每个月经周期消耗约 1000 个 (只有 1 个排卵, 其余凋亡)。到 40 岁时剩约 2-3 万, 不仅数量降, 染色体非整倍体率也从 30 岁的 < 10% 升到 40 岁的约 50%——这是自然流产和唐氏综合征风险随母龄上升的化学根源。
男性 · 更平缓但同样真实
男性生育能力的下降更平缓但同样真实:35 岁后精子 DNA 片段化升新发突变率上升 (父源相关), 父高龄 (> 45) 与孩子孤独症、精神分裂风险轻度上升关联但男性 70 岁仍可受孕, 数量曲线远比女性平缓
试管能补偿年龄吗
辅助生殖技术 (ART) 的现实:IVF (体外受精) 单周期活产率:
< 35 岁: 约 35-40%35-37 岁: 约 30%38-40 岁: 约 20%41-42 岁: 约 10%> 42 岁 (自体卵): 约 3-5%
ART 能补偿年龄是常见误解——ART 提高单周期效率, 但不能逆转卵母细胞质量退化。冻卵 (社交性) 34 岁前冻效果最好; > 38 岁冻, 取卵数和后续 IVF 成功率都明显下降。PGT-A (胚胎染色体筛查) 能提高单次移植成功率, 但不能凭空创造好胚胎。
一份少一点后悔的清单
实操原则 (减少未来后悔的一份清单):如果想生孩子, 30 岁前至少做过一次生育力评估 (AMH 加基础窦卵泡计数)——这不是催, 是给自己决策信息35 岁前未生育且想生: 半年试孕未果建议就诊不孕症门诊 (常规标准是 1 年, 35+ 缩短到 6 个月)不确定何时生: 可与生殖科咨询冻卵, 早决定胜过晚决定男性 35-45 岁: 也可以做精液分析加 DNA 片段化测试, 不只是女方的事有慢病或长期用药: 提前咨询孕产风险
没有对的年龄
社会层面的事实:晚生育的成本: 不孕症治疗经济负担、染色体异常风险、高龄孕产并发症早生育的成本: 职业、经济、婚姻准备度没有对的年龄, 但信息透明让人能主动选择, 而不是事后才知道
这一格的核心信息是: 生物时钟不是父权焦虑话术, 而是真实的化学事实。但它也不是命运——早知道、早评估、早决策, 个人能在生物约束内做出更多选择。
References · 13
- American College of Obstetricians and Gynecologists. (2021). Nutrition During Pregnancy (FAQ001) and Committee Opinion 762: Prepregnancy Counseling. www.acog.org/womens-health/faqs/nutrition-during-pregnancy
- World Health Organization. (2016). WHO recommendations on antenatal care for a positive pregnancy experience. WHO Press. www.who.int/publications/i/item/9789241549912
- MRC Vitamin Study Research Group. (1991). Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. The Lancet, 338(8760), 131-137. 10.1016/0140-6736(91)90133-A
- Centers for Disease Control and Prevention. (1992). Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recommendations and Reports, 41(RR-14), 1-7. www.cdc.gov/mmwr/preview/mmwrhtml/00019479.htm
- National Institutes of Health, Office of Dietary Supplements. (2024). Iron — Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/Iron-HealthProfessional
- Stoffel, N. U., Cercamondi, C. I., Brittenham, G., Zeder, C., Geurts-Moespot, A. J., Swinkels, D. W., et al. (2017). Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. The Lancet Haematology, 4(11), e524-e533. Cumulative fractional iron absorption was higher with alternate-day dosing (~21.8%) than consecutive-day dosing (~16.3%); single morning doses outperformed twice-daily split dosing. 10.1016/S2352-3026(17)30182-5
- Hibbeln, J. R., Davis, J. M., Steer, C., et al. (2007). Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. The Lancet, 369(9561), 578-585. 10.1016/S0140-6736(07)60277-3
- U.S. Food and Drug Administration & EPA. (2021). Advice About Eating Fish: For Those Who Might Become or Are Pregnant or Breastfeeding and Children Ages 1 to 11 Years. www.fda.gov/food/consumers/advice-about-eating-fish
- Mozaffarian, D., & Wu, J. H. Y. (2011). Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Journal of the American College of Cardiology, 58(20), 2047–2067. 10.1016/j.jacc.2011.06.063
- Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288(3), 321-333. 10.1001/jama.288.3.321
- Teede, H. J., Tay, C. T., Laven, J. J. E., et al. (2023). Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility, 120(4), 767-793. 10.1016/j.fertnstert.2023.07.025
- Lethaby, A., Marjoribanks, J., Kronenberg, F., Roberts, H., Eden, J., & Brown, J. (2013). Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database of Systematic Reviews, (12), CD001395. 10.1002/14651858.cd001395.pub4
- Camacho, E. M., Huhtaniemi, I. T., O'Neill, T. W., Finn, J. D., Pye, S. R., Lee, D. M., et al. (2013). Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. European Journal of Endocrinology, 168(3), 445-455. 10.1530/EJE-12-0890